These results suggest that downregulation of miR-33b could trigger oncogenic properties through activation of the TAK1/FASN/CPT1A/NF-κB signaling axis and, as a consequence, facilitate peritoneal metastases of ovarian cancer. Here, CPT1A is linked to ovarian cancer.